Hepatitis C among drug users: consensus guidelines on management in general practice
- 61 Downloads
Hepatitis C (HCV) is a common cause of morbidity among patients who attend general practitioners (GPs) in Ireland for methadone maintenance treatment.
To describe the development and content of guidelines for the management of HCV among current or former opiate users in the Eastern Regional Health Authority area attending GPs for methadone treatment.
The guidelines were produced in five stages: identification of key stakeholders; development of evidence-based draft guidelines; discussion of content; determination of ‘Delphi’-facilitated consensus and review by a sample of GPs for whom the guidelines would be intended.
The guidelines contain advice for GPs on all aspects of care of patients at risk of HCV, including general and preventative care, care of other bloodborne and hepatotoxic viruses, and the factors to be considered and appropriate evaluation prior to referring a patient for assessment at a hepatology unit.
GPs have an important role to play in the care of patients at risk of, or Infected with, HCV.
- 3.Prevalence of HCV among drug users attending general practice. Association of University Departments of General Practice Annual Scientific Meeting; 2000 July; Bournemouth.Google Scholar
- 5.Keenan E, Barry J. Managing drug misuse in general practice.Br Med J 1999; 319: 1497.Google Scholar
- 6.Woolf S, Grol R, Hutchinson A. Clinical guidelines: potential benefits limitations and harms of clinical guidelines.Br Med J 1999; 318: 527–30.Google Scholar
- 8.Desirable attributes of clinical practice guidelines. Washington: Institute of Medicine. National Academy Press, 1992.Google Scholar
- 9.Conroy M, Shannon W. Clinical guidelines: their implementation in general practice.Br J Gen Prac 1995; 45 (396): 371–5.Google Scholar
- 11.Jones J, Hunter D. Consensus methods for medical and health services research.Br Med J 1995; 311: 376–80.Google Scholar
- 12.Broomfield D, Humphris G. Using the Delphi technique to identify cancer education requirements of general practitioners.Med Edu 2001; 35 (10): 928–37.Google Scholar
- 13.Guidelines on the management of hepatitis C in general practice: a semiqualitative interview survey of GPs’ views regarding content and implementation. Joint Symposium of the Society for the Study of Addiction and the Faculty of Substance Misuse of the Royal College of Psychiatrists; 2002; Leeds, UKGoogle Scholar
- 14.MacDonald M, Wodak. Preventing transmission of hepatitis C.Australian Fam Phys 1999; 28 (Special Issue 15): 14–7.Google Scholar
- 15.Management of hepatitis C.NIH Consensus Statement 1997; 15 (3): In press.Google Scholar
- 16.MacDonald M, Crofts N, Kaldor J. Transmission of hepatitis C virus: rates, routes, and cofactors.Epidem Rev 1996; 18 (2): 137–48.Google Scholar
- 18.Consensus Statement. International Consensus Conference on hepatitis C; 1999 26–28 February; Paris. European Association for the Study of Liver Disease (EASL).Google Scholar
- 19.Sherman M. Management of viral hepatitis: clinical and public health perspectives — a consensus statement. CASL Hepatitis Consensus Group. Canadian Association for Study of the Liver.Can J Gastro 1997; 11 (5): 407–16.Google Scholar
- 24.Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease.Morbidity and Mortality Weekly Reports (MMWR): 1998: 1–39.Google Scholar
- 25.A strategy for the detection and management of hepatitis C in Australia. Canberra: National Health and Medical Research Council (NHMRC). Australian Government Publishing Service, 1997.Google Scholar
- 26.Garcia-Samaniego J, Soriano V, Castilla J. Influence of hepatitis C virus genotypes on histological severity of chronic hepatitis C. The Hepatitis/HIV Spanish Study Group.Am J Gastroentol 1997; 92: 1130–4.Google Scholar
- 27.Acharaya S, Dasarathy S, Kumer T et al. Fulminant hepatitis in a tropical population: clinical course, cause, and early predictors of outcome.Hepatology 1996; 23 (6): 1447–55.Google Scholar
- 30.Keating S. Vaccination guidelines for patients attending the ERHA drug treatment clinics. Dublin: Eastern Regional Health Authority, 2000.Google Scholar
- 31.Immunisation guidelines for Ireland: National Immunisation Committee, Royal College of Physicians of Ireland, 1999.Google Scholar
- 32.Immunological responses to hepatitis C and non-hepatitis C antigens in hepatitis C (HCV) and human immunodeficiency (HIV)-HCV coinfected patients. XIII International AIDS Conference; 2000; Durban, South Africa.Google Scholar
- 33.Melvin D, Lee J, Belsey E. The impact of co-infection with hepatitis C and HIV on the tolerability of antiretroviral therapy.AIDS Patient Care STDS 2000; 14: 463–85.Google Scholar
- 37.Kidd M, Cheng W, Wilson S. Initial management of hepatitis C.Aust Fam Phys 1999; 28: SI32–35.Google Scholar
- 38.McCoy R, Watson K, Kosky M. A guide to diagnosis.Aust Fam Phys 1999; 28: SI19-SI23.Google Scholar
- 41.Harley H, Shaw D, Steven I. Ongoing management of hepatitis C.Australian Fam Phys 1999; 28 (Special Issue): SI36–9.Google Scholar
- 45.Best D, Lehman P, Gossop M et al. Eating too little, smoking and drinking too much: wider lifestyle problems among methadone maintenance patients.Addiction 1998; 6: 290–1.Google Scholar
- 46.RACGP/ANCARD Hepatitis C algorithms.Aust Fam Phys 1999; 28 (SI 71): 72–7.Google Scholar